Home » Stocks » TMBR

Timber Pharmaceuticals, Inc. (TMBR)

Stock Price: $1.10 USD -0.17 (-13.39%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 48.02M
Revenue (ttm) 453,810
Net Income (ttm) -15.26M
Shares Out 15.70M
EPS (ttm) -0.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $1.10
Previous Close $1.27
Change ($) -0.17
Change (%) -13.39%
Day's Open 1.26
Day's Range 1.07 - 1.37
Day's Volume 5,700,529
52-Week Range 0.38 - 5.69


Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

- Edward J. Sitar appointed as Lead Independent Director of the Board -

2 weeks ago - GlobeNewsWire

So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.

Other stocks mentioned: ATNF, CTXR, JAGX, OCGN, SVRA, ZSAN
3 weeks ago - InvestorPlace

It's never a dull day on the Reddit Penny Stocks subreddit and we're checking in to see what's being talked about the most today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared...

Other stocks mentioned: ASRT, INPX, NAKD, ZOM
3 weeks ago - InvestorPlace

Reddit stocks continue to have the public's attention. These 7 could be the next short squeeze targets based on technical signs.

Other stocks mentioned: ATNF, BCEI, DISCB, RIOT, SNDL, HPR, OTRK
1 month ago - InvestorPlace

Basking Ridge, NJ, April 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber” or the "Company"), a biopharmaceutical company focused on the devel...

1 month ago - GlobeNewsWire

50% of patients in the Phase 2b CONTROL study have now been randomized despite COVID-19 disruptions in the trial marketplace

1 month ago - GlobeNewsWire

- Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe -

1 month ago - GlobeNewsWire

- Study is Evaluating TMB-001 (Topical Isotretinoin) in Subtypes of Rare Genetic Keratinization Disorder

1 month ago - GlobeNewsWire

Timber Pharmaceuticals spiked more than 75% in trading today following a virtual life sciences conference this week. Trading volume in TMBR stock was up more than 1600% on the day.

1 month ago - InvestorPlace

WOODCLIFF LAKE, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the de...

2 months ago - GlobeNewsWire

These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on...

Other stocks mentioned: BORR, EVFM, IBIO, KSHB, OILFF, SB
2 months ago - InvestorPlace

Dr. Mendelsohn has 20+ Years' Experience in Clinical Development and Medical Affairs

3 months ago - GlobeNewsWire

Timber Expects to Submit Investigational New Drug (IND) Application to the FDA in 2022

3 months ago - GlobeNewsWire

Call to be held on Thursday, December 17th at 11:00am EST

4 months ago - GlobeNewsWire

Presentation on Tuesday December 15th  at 10:40am EST

4 months ago - GlobeNewsWire

Biopharmx Corp shares spiked higher Tuesday morning after the company announced its Phase 2b trial of BPX-04 for Populopustular Rosacea has met both primary and secondary endpoints and was well tolerated.

Other stocks mentioned: BPMX
1 year ago - Benzinga

About TMBR

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical dermatology company, focused on the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements